GDS Wealth Management Increases Position in Oscar Health, Inc. (NYSE:OSCR)

GDS Wealth Management lifted its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 1,545.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 345,817 shares of the company's stock after buying an additional 324,798 shares during the quarter. GDS Wealth Management owned approximately 0.14% of Oscar Health worth $4,648,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of OSCR. Wealth Enhancement Advisory Services LLC raised its stake in shares of Oscar Health by 7.5% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock valued at $255,000 after acquiring an additional 844 shares in the last quarter. KBC Group NV increased its holdings in Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company's stock worth $97,000 after purchasing an additional 1,328 shares during the period. Allspring Global Investments Holdings LLC raised its position in Oscar Health by 1.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 109,074 shares of the company's stock valued at $2,313,000 after purchasing an additional 1,866 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Oscar Health by 9.2% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company's stock valued at $561,000 after buying an additional 2,236 shares during the period. Finally, nVerses Capital LLC grew its position in shares of Oscar Health by 36.1% during the third quarter. nVerses Capital LLC now owns 18,100 shares of the company's stock worth $384,000 after buying an additional 4,800 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on OSCR. Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and decreased their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Jefferies Financial Group began coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective for the company. Two research analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Oscar Health currently has a consensus rating of "Hold" and a consensus price target of $21.56.

Insider Activity

In related news, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of the company's stock in a transaction dated Tuesday, November 12th. The shares were acquired at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the completion of the acquisition, the director now owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. This trade represents a 8.36 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mario Schlosser sold 6,516 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $117,809.28. Following the sale, the insider now directly owns 81,962 shares of the company's stock, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Corporate insiders own 25.11% of the company's stock.

Oscar Health Stock Down 0.4 %

NYSE:OSCR traded down $0.07 during midday trading on Friday, hitting $14.72. 4,028,930 shares of the company were exchanged, compared to its average volume of 3,872,617. Oscar Health, Inc. has a fifty-two week low of $13.05 and a fifty-two week high of $23.79. The company has a market capitalization of $3.64 billion, a PE ratio of -245.21, a price-to-earnings-growth ratio of 0.67 and a beta of 1.73. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a fifty day simple moving average of $15.09 and a 200 day simple moving average of $16.82.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. As a group, equities analysts anticipate that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.